Skip to main content
SpringerLink
Log in

Endocrine Myopathies

  • Chapter
Muscle Imaging in Health and Disease

Abstract

Muscular involvement is common in endocrine diseases and does not generally pose a substantial diagnostic problem. Imaging and spectroscopic techniques used in the exploration of muscle are mainly complementary to pathophysiological studies. An exception to this rule is thyroid associated ophthalmopathy (Graves’ ophthalmopathy). In the evaluation of this particular disease, diagnostic imaging techniques such as ultrasound, CT, and MRI are of considerable clinical importance.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Char DH. The ophthalmopathy of Graves’ disease. Med Clin North Am 1991;75:97–119.

    PubMed  CAS  Google Scholar 

  2. Gorman CA. Extrathyroid manifestations of Graves’ disease. In: Ingbar SH, Braverman LE, editors. The thyroid: a fundamental and clinical text. Philadelphia: J.B. Lippincott Co, 1986:1015–1035.

    Google Scholar 

  3. Enzmann DR, Donaldson SS, Kriss JP. Appearance of Graves’ disease on orbital computed tomography. J Corn-put Assist Tomogr 1979;3:815–8819.

    CAS  Google Scholar 

  4. Werner SC, Coleman DJ, Franzen LA. Ultrasonographic evidence of a consistent orbital involvement in Graves’ disease. N Engl J Med 1974;290:1447–1450.

    Article  PubMed  CAS  Google Scholar 

  5. Gorman CA. Temporal relationship between onset of Graves’ ophthalmopathy and diagnosis of thyrotoxicosis. Mayo Clin Proc 1983;58:583–588.

    Google Scholar 

  6. Werner S. Modification of the classification of the eye changes of Graves’ disease: recommendations of the Ad Hoc Commitee of the American Thyroid Association. J Clin Endocrinol Metab 1977;44:203–204.

    Article  PubMed  CAS  Google Scholar 

  7. Trokel SL, Jakobiec FA. Correlation of CT scanning and pathologic features of ophthalmic Graves’ disease. Ophthalmology 1981;88:553–564.

    PubMed  CAS  Google Scholar 

  8. Coleman DJ, Jack RL, Franzen LA, Werner SC. High resolution B-scan ultrasonography of the orbit. Arch Ophthalmol 1972;88:465–480.

    PubMed  CAS  Google Scholar 

  9. Coleman DJ, Woods S, Rondeau M, Silverman RH. Ophthalmic ultrasonography. Radiol Clin North Am 1992;30:1105–1113.

    PubMed  CAS  Google Scholar 

  10. Willinsky RA, Arenson AM, Hurwitz JJ, Szalai J. Ultrasonic B-scan measurement of the extra-ocular muscles in Graves’ orbitopathy. J Can Assoc Radiol 1984;35:171–173.

    PubMed  CAS  Google Scholar 

  11. Byrne SF, Glaser JS. Orbital tissue differentiation with standardized echography. Ophthalmology 1983;90: 1071–1090.

    PubMed  CAS  Google Scholar 

  12. Ossoinig KC. Standardized echography: basic principles, clinical applications, and results. Int Ophthalmol Clin 1979;19:127–210.

    Article  PubMed  CAS  Google Scholar 

  13. Peyster RG. Computed tomography of the orbit. In: Gonzalez CF, Becker MH, Flanagan JC, editors. Diagnostic imaging in ophthalmology. New York: Springer-Verlag, 1986:19–37.

    Google Scholar 

  14. Hilal SK. Computed tomography of the orbit. Ophthalmology 1979;86:864–870.

    PubMed  CAS  Google Scholar 

  15. Markl AF, Hilberts T, Mann K. Graves’ ophthalmopathy: standardized evaluation of computed tomography examinations; magnetic resonance imaging. Dev Ophthalmol (Basel) 1989;20:38–50.

    CAS  Google Scholar 

  16. Rothfus WE, Curtin HD. Extraocular muscle enlargement: a CT review. Radiology 1984;151:677–681.

    PubMed  CAS  Google Scholar 

  17. Sowinski J, Ziemianski A, Gembicki M. Computerized tomography in Graves’ immunoophthalmopathy. Radio-biol Radiother 1984;25:749–754.

    CAS  Google Scholar 

  18. Trokel SL, Hilal SK. Recognition and differential diagnosis of enlarged extraocular muscles in computed tomography. Am J Ophthalmol 1979;87:503–512.

    PubMed  CAS  Google Scholar 

  19. Wing SD, Hunsaker JN, Anderson RE, Van Dyck HJL, Osborn AG. Direct sagittal computed tomography in Graves’ ophthalmopathy. J Comput Assist Tomogr 1979; 3:820–824.

    PubMed  CAS  Google Scholar 

  20. Forbes G, Gorman CA, Brennan MD, Gehring DG, Ilstrup DM, Earnest FI. Ophthalmopathy of Graves’ disease: computerized volume measurements of the orbital fat and muscle. Am J Neuroradiol 1986;7;651–656.

    PubMed  CAS  Google Scholar 

  21. Forbes G, Gorman CA, Gehring D, Baker HL. Computer analysis of orbital fat and muscle volumes in Graves ophthalmopathy. Am J Neuroradiol 1983;4:737–740.

    PubMed  CAS  Google Scholar 

  22. Trokel SL, Hilal SK. Submillimeter resolution CT scanning of orbital diseases. Ophthalmology 1980;87:412–417.

    PubMed  CAS  Google Scholar 

  23. Hawkes RC, Holland GN, Moore WS, Rizk S, Worthington BS, Kean DM. NMR imaging in the evaluation of orbital tumors. Am J Neuroradiol 1983;4:254–256.

    PubMed  CAS  Google Scholar 

  24. Hosten N, Sander B, Cordes M, Shubert CJ, Schörner W, Felix R. Graves ophthalmopathy: MR imaging of the orbits. Radiology 1989;172:759–762.

    PubMed  CAS  Google Scholar 

  25. Li KC, Poon PY, Hinton P, et al. MR imaging of orbital tumors with CT and ultrasound correlations. J Comput Assist Tomogr 1984;8:1039–1047.

    Article  PubMed  CAS  Google Scholar 

  26. Roden DT, Savino PJ, Zimmerman RA. Magnetic resonance imaging in orbital diagnosis. Radiol Clin North Am 1988;26:535–545.

    PubMed  CAS  Google Scholar 

  27. Just M, Kahaly G, Higer HP, et al. Graves ophthalmopathy: role of MR imaging in radiation therapy. Radiology 1991; 179:187–190.

    PubMed  CAS  Google Scholar 

  28. Kaissar G, Kim JH, Bravo S, Sze G. Histologic basis for increased extraocular muscle enhancement in gadolinium-enhanced MR imaging. Radiology 1991;179:541–542.

    PubMed  CAS  Google Scholar 

  29. Pozzo GD, Boshi MC. Extraocular muscle enlargement in acromegaly. J Comput Assist Tomogr 1982;6:706–707.

    Article  Google Scholar 

  30. Gean-Marton AD, Kirsch CFE, Vezina LG, Weber AL. Focal amyloidosis of the head and neck: evaluation with CT and MR imaging. Radiology 1991;521:521–525.

    Google Scholar 

  31. Ruff RL. Endocrine myopathies (hyper- and hypofunction of adrenal, thyroid, pituitary and parathyroid glands and iatrogenic steroid myopathy). In: Engel AG, Banker BQ, editors. Myology. New York: McGraw-Hill Book Co., 1986:1871–1906.

    Google Scholar 

  32. Ramsay ID. Electromyography in thyrotoxicosis. Q J Med 1965;34:255–258.

    PubMed  CAS  Google Scholar 

  33. Zürcher RM, Horber FF, Grünig BE, Frey FJ. Effect of thyroid dysfunction on thigh muscle efficiency. J Clin Endocrinol Metab 1989;69:1082–1086.

    Article  PubMed  Google Scholar 

  34. Serratrice G, Salamon G, Jiddane M, Gastaut JL, Pelissier JF, Pouget J. Results of CT examination of muscles in 145 cases of neuromuscular diseases. Rev Neurol (Paris) 1985;141:404–412.

    CAS  Google Scholar 

  35. Huppert D, Witt TN, Nägele M. Chronisch-hyperthreote Myopathic Ein Beitrag zur Differentialdiagnose des myopathischen Gliedergürtelsyndroms. Nervenarzt 1991;62:374–377.

    PubMed  CAS  Google Scholar 

  36. Kaminsky P, Robin-Lherbier B, Walker P, et al. Muscle bioenergetic impairment in hyperthyroid man: a study by 31 NMR spectroscopy. Acta Endocrinol (Copenh) 1991;124:271–277.

    CAS  Google Scholar 

  37. Argov Z, Renshaw PF, Boden B, Winokur A, Bank WJ. Effects of thyroid hormones on skeletal muscle bioenergetics: in vivo phosphorus-31 magnetic resonance spectroscopy study of humans and rats. J Clin Invest 1988;81:1695–1701.

    Article  PubMed  CAS  Google Scholar 

  38. Martin WHI, Spina RJ, Korte E, et al. Mechanisms of impaired exercise capacity in short duration experimental hyperthyroidism. J Clin Invest 1991;88:2047–2053.

    Article  PubMed  CAS  Google Scholar 

  39. Astrom KE, Kugelberg E, Muller R. Hypothyroid myopathy. Arch Neurol 1961;5:472–482.

    PubMed  CAS  Google Scholar 

  40. Klein I, Parker M, Shebert R, Ayyar DR, Levey GS. Hypothyroidism presenting as muscle stiffness and pseu-dohypertrophy: Hoffmann’s syndrome. Am J Med 1981; 70:891–894.

    Article  PubMed  CAS  Google Scholar 

  41. Pearce J, Aziz H. The neuromyopathy of hypothyroidism. J Neurol Sei 1969;9:243–253.

    Article  CAS  Google Scholar 

  42. Khaleeli ALIA, Gohil K, McPhail G, Round JM, Edwards RHT. Muscle morphology and metabolism in hypothyroid myopathy: effects of treatment. J Clin Pathol 1983;36: 519–526.

    Article  PubMed  CAS  Google Scholar 

  43. Norris FH, Panner BJ Hypothyroid myopathy. Clinical, electromyographical and ultrastructural observations Arch Neurol 1966;14:574–589.

    PubMed  Google Scholar 

  44. Kaminsky P, Robin-Lherbier B, Brunotte F, et al. Energetic metabolism in hypothyroid skeletal muscle, as studied by phosphorus magnetic resonance spectroscopy. J Clin Endocrinol Metab 1992;74:124–129.

    Article  PubMed  CAS  Google Scholar 

  45. Argov Z, Bank WJ, Maris J, Peterson P, Chance B. Bioenergetic heterogeneity of human mitochondrial myopathies as demonstrated by in vivo phosphorus magnetic resonance spectroscopy. Neurology 1987;37:257–262.

    PubMed  CAS  Google Scholar 

  46. Arnold DL, Taylor DJ, Radda GK. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann Neurol 1985;18:189–196.

    Article  PubMed  CAS  Google Scholar 

  47. Kaminsky P, Klein M, Robin-Lherbier B, et al. A 31 NMR study of different hypothyroid states in rat leg muscle. Am J Physiol 1991;262(24):E706–E712.

    Google Scholar 

  48. Taylor DJ, Rajagopalan B, Radda GK. Cellular energetics in hypothyroid muscle. Eur J Clin Invest 1992;22:358–365.

    Article  PubMed  CAS  Google Scholar 

  49. Parker DF, Round JM, Sacco P, Jones DA. A cross sectional survey of upper and lower limb strength in boys and girls during childhood and adolescence. Ann Hum Biol 1990;17:199–211.

    Article  PubMed  CAS  Google Scholar 

  50. Jorgensen JOL, Pedersen SA, Thuesen L, et al. Beneficial effects of growth hormone treatment in GH-deficient adults Lancet 1989;i:1221–1225.

    Article  Google Scholar 

  51. Rutherford OM, Jones DA, Round JM, Buchanan CR, Preece MA. Changes in skeletal muscle and body composition after discontinuation of growth hormone treatment in growth hormone deficient young adults. Clin Endocrinol 1991;34:469–475.

    Article  CAS  Google Scholar 

  52. Leger J, Garel C, Legrand I, Paulsen A, Hassan M, Czernichow P. Magnetic resonance imaging of the metabolic effects of GH on muscle and fat mass in children [abstract]. Abstracts of the Ninth International Congress of Endocrinology, Nice, France, August 30-September 5, 1992:292.

    Google Scholar 

  53. Kaminsky P, Klein M, Walker PM, Straczek J, Forrett MC, Due M. GH effects on muscle bioenergetics in-vivo [abstract]. Abstracts of the Ninth International Congress of Endocrinology, Nice, France, August 30-September 5, 1992;292.

    Google Scholar 

  54. Mastiglia FL, Barwick DD, Hall R Myopathy in acromegaly Lancet 1970;ii:907–909.

    Article  Google Scholar 

  55. Pickett JBE, Layser RB, Levin SR, Schneider V, Campbell MJ, Sumner AG. Neuromuscular complications of acromegaly. Neurology 1975;25:638–645.

    PubMed  CAS  Google Scholar 

  56. Bigland B, Jehring B. Muscle performance in rats, normal and treated with growth hormone. J Physiol (Lond) 1952; 116:129–136.

    CAS  Google Scholar 

  57. Horber FF, Scheidegger JR, Grünig BE, Frey FJ. Evidence that prednisone-induced myopathy is reversed by physical training. J Clin Endocrinol Metab“985;61:83–87.

    Google Scholar 

  58. Khaleeli AA, Betteridge DJ, Edwards RHT, Round JM, Ross EJ. Effect of treatment of Cushing’s syndrome on skeletal muscle structure and function. Clin Endocrinol 1983;19:547–556.

    Article  CAS  Google Scholar 

  59. Smith R, Newman RJ, Radda GK, Stokes M, Young A. Hypophosphataemic osteomalacia and myopathy: studies with nuclear magnetic resonance spectroscopy. Clin Sei 1984;67:505–509.

    CAS  Google Scholar 

  60. Bollaert PE, Gimenez M, Robin-Lherbier B, et al. Respective effects of malnutrition and phosphate depletion on endurance swimming and muscle metabolism in rats. Acta Physiol Scand 1992;144:1–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Pierre Kaminsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul M. Walker
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiology, University of Texas Southwestern Medical Center at Dallas, 75235-9071, Dallas, TX, USA

    James L. Fleckenstein MD

  2. RadNet, Inc, 90025-3303, Los Angeles, CA, USA

    John V. Crues III MD

  3. Abteilung für Klinische Neurophysiologie, Universität Göttingen, 37075, Göttingen, Germany

    Carl D. Reimers MD

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Kaminsky, P., Walker, P.M. (1996). Endocrine Myopathies. In: Fleckenstein, J.L., Crues, J.V., Reimers, C.D. (eds) Muscle Imaging in Health and Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2314-6_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-2314-6_20

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7498-8

  • Online ISBN: 978-1-4612-2314-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation